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ABSTRACT 
Differences in Upper Body Posture and Postural Muscle Activation in Females with 
Larger Breast Sizes  
  
 Breast hypertrophy is a common medical condition whose morbidity has 
increased over recent decades.  Symptoms of breast hypertrophy often include 
musculoskeletal pain in the neck, back and shoulders, and numerous psychosocial health 
burdens.   To date, reduction mammaplasty (RM) is the only treatment shown to 
significantly reduce the severity of the symptoms associated with breast hypertrophy.  
However, due to a lack of scientific evidence in the medical literature justifying the 
medical necessity of RM, insurance companies often deny requests for coverage of this 
procedure.  Therefore, the purpose of this study is to investigate biomechanical 
differences in the upper body of women with larger breast sizes in order to provide 
scientific evidence of the musculoskeletal burdens of breast hypertrophy to the medical 
community   
 Twenty-two female subjects (average age 25.90, ± 5.47 years) who had never 
undergone or been approved for breast augmentation surgery, were recruited to 
participate in this study.  Kinematic data of the head, thorax, pelvis and scapula was 
collected during static trials and during each of four different tasks of daily living.  
Surface electromyography (sEMG) data from the Midcervical (C-4) Paraspinal, Upper 
Trapezius, Lower Trapezius, Serratus Anterior, and Erector Spinae muscles were 
recorded in the same activities.  Maximum voluntary contractions (MVC) were used to 
normalize the sEMG data, and %MVC during each task in the protocol was analyzed.  
Kinematic data from the tasks of daily living were normalized to average static posture 
data for each subject.  Subjects were divided into groups of normal control subjects 
(n=12, reported bra-cup size A, B, or C) or hypertrophy subjects (n=10, reported bra-cup 
size D or larger).  To compare results between the groups, a two-tailed independent t-test 
was performed for each dependent variable with significance set at α=0.05. 
 Significant differences in torso flexion were found between the normal control 
group and the hypertrophy group during both the pencil activity (p=0.054) and the step 
up activity (p=0.001).  There were also significant differences in lower trapezius muscle 
activation during the static trial (p=0.051).  Although not significant, women in the 
hypertrophy group also tended to exhibit greater head flexion, pelvic tilt and torso flexion 
under static conditions, and also exhibited increased muscle activation in all five muscles 
under the same conditions.  
Results of this study provide scientific information regarding the effects of breast 
hypertrophy on the musculoskeletal system.  While none of the postural alterations seen 
in women with large breasts were significantly different from those seen in women with 
smaller breasts, the data presented shows a trend towards altered musculoskeletal 
alignment due to the size and weight of larger breasts that should be considered when 
determining the medical necessity of reduction mammaplasty.     
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INTRODUCTION 
Breast hypertrophy is a common medical condition whose morbidity has 
increased over recent decades.  While the exact definition of breast hypertrophy is 
unclear, it is characterized by an increase in the volume and weight of breast tissue 
beyond normal proportions [1]. The exact etiology of breast hypertrophy is unknown, 
especially when it occurs during puberty and early adolescence.   
Common symptoms associated with breast hypertrophy include pain in the neck, 
back and shoulders, intertrigo, shoulder grooving from bra straps, headaches, rash, and 
breast pain [2-9].  Women with breast hypertrophy may also report neurologic symptoms 
of the upper extremity such as ulnar nerve neuropathies, hand numbness, and carpal 
tunnel syndrome [1, 4, 8-14].  
Psychosocial burdens are also associated with breast hypertrophy.  Many women 
with breast hypertrophy report feelings of embarrassment, difficulty finding properly 
fitting clothing, low self-esteem, and difficulty participating in sports [12, 13, 15, 16].  As 
a result, women with hypertrophic breasts are often dissatisfied with their self-image and 
may seek reduction mammaplasty as a way to reduce both pain and psychosocial distress. 
To date, there is no lasting non-operative treatment for breast hypertrophy [1].  As 
a result, women with severe breast hypertrophy are most often treated by reduction 
mammaplasty.  Bilateral reduction mammaplasty is a surgical technique in which excess 
breast tissue is removed from both breasts.  Objectives of reduction mammaplasty 
include: lifting of the nipple and areola, reduction of the breast skin envelope, overall 
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improvement in the shape of the breast, and preservation of lactation and breast 
sensitivity [17, 18].  Reduction mammaplasty is the only treatment proven to effectively 
reduce the severity of the symptoms associated with breast hypertrophy.   
Over the past few years reduction mammaplasty has become one of the most 
common reconstructive surgical procedures performed by plastic surgeons in the United 
States.  The number of reduction mammaplasty surgeries performed each year has 
increased 25% since 2000.  In 2007, 106,179 breast reductions were performed, making 
reduction mammaplasty the number five reconstructive procedure in 2007 [19].   
Recent research has examined the correlation between the relief of the symptoms 
of breast hypertrophy and surgery.  Most recently, a study entitled “Breast Reduction: 
Assessment of Value and Outcomes” (BRAVO) was performed using validated self-
report questionnaires to evaluate the burden of breast hypertrophy.  This multicenter 
study comparatively assessed both women presenting for breast reduction and a control 
group of large-breasted women.  This study found that women presenting for surgery 
experienced more breast-related symptoms (especially pain) relative to the control group, 
were unable to obtain long-term relief of symptoms form conservative treatments, and 
reported substantial pain relief following breast reduction surgery, essentially allowing 
them to return to normal functioning.  Based on the results of this study, Kerrigan et al 
were able to define the medical necessity of breast reduction surgery, and determined that 
women reporting two or more of the key physical symptoms all or most of the time had 
the most substantial health burden and were most likely to benefit from surgery [1, 20].   
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Despite increasing recognition of breast hypertrophy as a morbid disease, the 
debate over whether reduction mammaplasty should be considered a cosmetic or 
reconstructive procedure continues.  While many prospective studies have been published 
indicating the positive health related outcomes of reduction mammaplasty, no studies to 
date have provided solid objective measurements as evidence of variables that indicate 
when reduction mammaplasty becomes medically necessary.  As a result, insurance 
companies often reject patients who do not meet their arbitrary requirements for 
determining medical necessity despite having obvious symptoms. 
Problem Statement 
The purpose of this study is to investigate biomechanical differences in the upper 
body of women with larger breast sizes in order to provide scientific evidence of the 
musculoskeletal burdens of breast hypertrophy to the medical community.  For the 
purposes of this study, subjects were divided into groups of normal control subjects 
(reported bra-cup size A, B, or C) or hypertrophy subjects (reported bra-cup size D or 
larger) [21].  The evaluation of each subject has three primary objectives: 
Objective 1 
 Quantify the kinematics of the head, thorax, pelvis and scapula during different 
tasks of daily living in comparison to the same kinematics during a static standing trial.  
The kinematic variables of interest will be: Head flexion and extension, thoracic flexion 
and extension, pelvic tilt, scapular protraction and retraction, scapular upward rotation, 
and lateral torso flexion. 
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Objective 2 
 Quantify the maximum amplitude (%MVC) of muscle activation of each of the 
muscles of interest during each task of daily living in comparison to the maximum 
amplitude (%MVC) of muscle activation of each muscle during a static standing trial. 
 
Objective 3 
 Quantify the health burden of breast hypertrophy based on the breast symptom 
summary score (BSS), calculated from the Breast Related Symptoms Questionnaire 
(BRSQ).    
Research Hypothesis 
Based on these three objectives, the research hypothesis for this study is that the 
BSS scores, upper body biomechanics, and cervico-thoracic muscle activation will differ 
between the two groups due to the size and weight of their breasts.  Based on the research 
hypothesis for this study, the statistical hypotheses in terms of the null hypothesis (Ho) 
and alternative hypothesis (Ha) for this study are: 
 Ho = 21    (Normal control subjects and Hypertrophy subjects will exhibit the 
same) 
o BSS scores 
o Muscle Activation 
o Head Flexion and Extension 
o Torso Flexion and Extension 
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o Pelvic Tilt 
o Scapular Protraction and Retraction 
o Scapular Rotation 
o Lateral Torso Flexion  
 Ha = 21   (Normal control subjects and Hypertrophy subjects will exhibit 
different) 
o BSS scores 
o Muscle Activation 
o Head Flexion and Extension 
o Torso Flexion and Extension 
o Pelvic Tilt 
o Scapular Protraction and Retraction 
o Scapular Rotation 
o Lateral Torso Flexion  
 
Assumptions 
 It is assumed that subjects performed each task as they would if no one was 
watching them so that movement can be accurately assessed and normalized 
across tasks. 
 All subjects were required to wear a regular (non sports) bra during testing.  It is 
assumed that the support given by the bra (i.e. location of bra straps, presence of 
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underwire) is uniform across all subjects and has minimal, if any, effect on the 
biomechanics of the musculoskeletal system. 
 
Limitations 
The results of this study will be limited by the group of women represented in the 
sample population: women over the age of 18 who have never undergone or been 
approved for breast augmentation surgery. 
 
Delimitations 
This study will be applicable to all females who have never undergone breast 
augmentation surgery.     
 
Operational Definitions 
This study will examine 8 distinct dependent variables, each of which presents a 
specific method of measurement. 
 Breast Related Symptoms Scores (BSS): Computed by averaging the item scores 
from the Breast Related Symptoms Questionnaire and linearly transforming the 
average to a 0-to-100 scale.  
 Muscle Activation: Reported as a percentage of maximum muscle contraction for 
each muscle of interest 
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 Head Flexion:  Quantified using a 6-camera optical motion camera system and 
reported in units of degrees.  Values were normalized as an average of the 
maximum change from static measurements, with positive values representing 
head flexion. 
 Torso Flexion and Extension:  Quantified using a 6-camera optical motion camera 
system and reported in units of degrees.  Values were normalized as an average of 
the maximum change from static measurements, with positive values representing 
torso flexion. 
 Pelvic Tilt:  Quantified using a 6-camera optical motion camera system and 
reported in units of degrees.  Values were normalized as an average of the 
maximum change from static measurements, with positive values representing 
anterior tilt. 
 Scapular Protraction:  Quantified using a 6-camera optical motion camera system 
and reported in units of degrees.  Values were normalized as an average of the 
maximum change from static measurements, with positive values representing 
shoulder protraction. 
 Scapular Upward Rotation:  Quantified using a 6-camera optical motion camera 
system and reported in units of degrees.  Values were normalized as an average of 
the maximum change from static measurements, with positive values representing 
upward rotation.   
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 Lateral Torso Flexion:  Quantified using a 6-camera optical motion camera 
system and reported in units of degrees.  Values were normalized as an average of 
the maximum change from static measurements, with positive values representing 
flexion towards the left side of the body. 
BSS scores will only be computed at the beginning of the data collection since that is 
the only time they will be measured.  The remaining dependent variables will be 
measured during both static trials and during each task of daily living trial with the 
exception of scapular upward rotation and lateral torso flexion, which will only be 
measured during lift and static trials.   
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REVIEW OF LITERATURE 
Breast hypertrophy has been widely associated with both physical and 
psychosocial symptoms.  Many qualitative studies have provided insight on the lessening 
of severity of these symptoms following reduction mammaplasty, yet few studies have 
aimed to explain the mechanism of the musculoskeletal pain seen among women with 
larger breasts.   
While several surgical procedures have been presented to achieve reduction in 
breast size, the degree of relief of breast hypertrophy symptoms does not appear to be 
related to the surgical procedure chosen.  Therefore, for the purposes of this study, the 
different types of surgical procedures will not be outlined and this review will focus 
solely on breast hypertrophy and its effects on the spinal column, the health-related 
quality of life of women with breast hypertrophy, alternative methods of treatment, and 
determination of coverage by third party payers. 
Breast Hypertrophy and the Spinal Column 
Deviated posture of the head, neck and shoulders has long been recognized as a 
potential contributing factor of the onset of upper body musculoskeletal pain.  Posture is 
maintained by ligamentous and muscular support as a result of the body’s effort to remain 
erect [8].  Research suggests that breast hypertrophy causes postural alterations related to 
the skeletal system, specifically the spinal column.     
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In general, the spinal column is a fairly flexible unit which can change shape on a 
limited basis in order to adjust to the location of the body’s center of gravity [8].  In 
individuals without significant postural deviations, the center of gravity of the human 
body profile passes from the external auditory meatus, through the odontoid process, 
slightly posterior to the center of the hip joint, slightly anterior to the center of the knee, 
and to a point slightly anterior to the lateral malleoli [8, 22].  However, in women with 
breast hypertrophy, the nipple descends to a lower position than the ideal [1], leading to 
secondary effects related to the location of the center of gravity.  This change in location 
of the center of gravity causes increased curvature of the cervical spine (increased 
cervical lordosis or head flexion) and increases the tension in the cervical extensor 
muscles [5, 8].    
The increased curvature of the cervical spine commonly seen in women with 
hypertrophic breasts may also place the head and shoulders forward, causing further 
postural alterations.  Forward head position is defined as excessively anterior position of 
the head in relation to a theoretical plumb line perpendicular to the body’s center of 
gravity [23].  It has been postulated that forward head position of the head may result in a 
sustained isometric contracture of the neck muscles [8, 24].  As mentioned before, pain in 
the head, neck and shoulders are common symptoms seen in women with breast 
hypertrophy [2-9]. These common symptoms may be explained as a result of the fatigue 
experienced by the muscles in the neck while trying to maintain this faulty forward head 
position [8, 23].  
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Forward head position has also been associated with an increase in thoracic 
kyphosis angle and may also lead to a downward rotation of the scapula and acromion, 
placing the shoulders in a deviated forward position [8, 24, 25].  This altered scapula 
position may decrease the range of motion of the upper extremity and change the 
biomechanics of the shoulder joint, resulting in musculoskeletal pain over time.    
In women with breast hypertrophy, the altered position of the scapula due to the 
weight of the breasts may lead to swelling and stiffness of the rotator cuff and can induce 
painful, limited motion of the shoulder girdle [8, 24].  Thus, women who suffer from 
breast hypertrophy may suffer from functional disabilities in the upper body, and may be 
limited in their ability to perform tasks of daily living due to decreased range of motion 
of the shoulder girdle.   
Changes in skeletal alignment may promote muscular changes that create 
excessive or abnormal muscle tension.  Posturally induced muscle weakness has been 
defined as the effect on muscles of remaining in a lengthened condition, however slight, 
beyond the neutral (physiological rest) position [26].  Therefore, if a muscle becomes 
positionally elongated, it is likely that this muscle will become relatively weak over time.  
Similarly, a muscle that becomes positionally shortened will become relatively stronger 
over time.   
Changes in the direction of muscle pull as a result of an altered scapula position 
may affect the amount of muscle tension required to maintain a static position [23], thus 
inducing fatigue and weakness in the scapula musculature similar to that seen in patients 
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who present with shoulder impingement syndrome.  Kisner and Colby suggest that 
increased scapular abduction or a “forward shoulders” posture may be partly caused by 
weakness of the scapular retractors, such as the upper trapezius, lower trapezius, and 
rhomboid muscles [26].   Similarly, Zimmerman et al propose that heavy breasts lead to 
gradual and continuous tension on the middle and lower trapezius muscle fibers 
consequently contributing to the shoulder pain in women with breast hypertrophy present 
[8].   
Along with musculoskeletal pain, women with breast hypertrophy may present 
with neurological complications. It has also been suggested by several authors that the 
altered position of the scapula results in compression of the brachial plexus, thus leading 
to neurologic complications of the upper extremity [10, 27].  Neurologic complications 
often include ulnar nerve paresthesis, hand numbness and carpal tunnel syndrome [4, 8-
14].  It is speculated that the brachial plexus compression between the coracoid process 
of the scapula and the rib cage occurs as forward depression of the shoulders tilts the 
coracoid downward in women with breast hypertrophy [10].       
In a study by Kaye et al, it was found that almost all women tested presented with 
characteristic area of ulnar hypesthesia in each hand regardless of complaints of pain or 
numbness in their hands [27].  While ulnar hypesthesia should not be disregarded as a 
symptom seen in women with breast hypertrophy, it is important to note that this study 
gives very little information about the methods used to gather data, and should therefore 
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not be treated as true scientific evidence of its association with the symptoms of breast 
hypertrophy.   
Health-Related Quality of Life 
Breast hypertrophy has been shown to create significant social and psychological 
problems for the women who suffer from this condition.  Major psychosocial complaints 
of women presenting with breast hypertrophy include:  unwanted attention, poor self-
esteem, difficulty finding proper fitting clothing, difficulty and embarrassment during 
exercise, negative impact on intimate relationships, and avoidance of social occasions [2, 
4, 15, 28].  
A myriad of physician-based questionnaires have been used in an attempt to 
evaluate the health-related quality of life of women with hypertrophic breasts.  One of the 
most well documented tools for evaluating physical and mental health-related quality of 
life is Short Form 36 [2, 14, 21, 28, 29].  Short Form 36 (SF-36) includes eight domains: 
physical function and activities, daily activities, emotional status, social activities, mental 
health, vitality and energy, pain, and general health perceptions. For each domain, higher 
scores indicate better health status and higher quality of life [21].   
Several studies on outcomes of reduction mammaplasty have shown that women 
with symptoms of breast hypertrophy score significantly lower preoperatively on SF-36 
than women representing the normal population [2, 7, 13, 14, 17, 21, 28-30].  These 
findings indicate that women who suffer from breast hypertrophy have a lower perceived 
health-related quality of life than the normal female population.  These same studies also 
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found that despite low preoperative scores on SF-36, reduction mammaplasty resulted in 
improved postoperative (3 to 12 months) scores on SF-36 [2, 14, 21, 28, 30].  Most 
notably, a prospective questionnaire study conducted by Blomqvist et al in 2000 
evaluated reduction mammaplasty patients SF-36 scores preoperatively and 
postoperatively (6 and 12 months) in comparison to an age-matched group of Swedish 
women.  In this study, patients who underwent reduction mammaplasty scored 
significantly higher on SF-36 6 and 12 months postoperatively and were similar to the 
SF-36 scores for the age-matched group [2].  These results not only indicate 
improvement, but normalization.  
More recently, Kerrigan et al developed a new self-report questionnaire in order 
to systematically quantify breast-specific symptoms.  The Breast Related Symptoms 
Questionnaire (BRSQ) is a 13-item condition specific questionnaire which encompasses 
both psychological and physical symptoms typically seen in women with breast 
hypertrophy.  In their study associated with the BRAVO (Breast Reduction: Assessment 
of Value and Outcomes) study, Kerrigan et al found that women who presented for 
surgical correction of their breast hypertrophy scored more poorly on the BRSQ than did 
both the hypertrophy control subjects (bra cup size > D) and the normal control subjects 
(bra cup size A, B, or C) [21].  Results from this extensive study suggest that symptoms 
are a better indicator of which women have the greatest health burden than are physical 
measurements such as breast volume.    
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The data from all these studies clearly demonstrates that breast hypertrophy has a 
significant impact on a women’s health-related quality of life and that symptoms of 
breast hypertrophy are a legitimate indicator of medical necessity for reduction 
mammaplasty surgery.  More importantly, there is no evidence provided in these studies 
that indicates that patient satisfaction or symptom improvement is enhanced with a 
greater amount of tissue removed [12], further supporting the fact that reduction should 
be considered a medically necessary procedure and not cosmetic in nature. 
Alternatives to Reduction Mammaplasty 
Insurance companies often require women who present with breast hypertrophy to 
try other forms of nonsurgical pain treatment before they will cover the costs of surgery.  
The length of time insurance companies require the patient to participate in nonsurgical 
therapy for management of pain ranges from six weeks to six consecutive months [11, 
31-34].  Common nonsurgical pain treatments include weight loss, aerobic exercise, use 
of specialized support bras, stretching, strength exercises and postural training, 
relaxation, heat application, hydrotherapy, back brace, medications, chiropractic 
treatment, acupuncture and physical therapy. [1, 28].  
While some nonsurgical treatments may provide temporary relief of pain, none of 
these treatments have been shown to provide full operative relief to woman seeking 
reduction mammaplasty surgery [28].  One of the most common nonsurgical treatments 
many insurance companies require patients to try is weight loss due to their requirements 
that patients be within 20% of ideal body weight prior to surgery [32].  This criterion is 
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set under the premise that a lower body weight or body mass index will result in a greater 
relief of symptoms. However, research evidence does not support this assumption as it 
has been shown that symptom relief is independent of preoperative weight [14].  While 
weight reduction alone may have an effect on the breast, it will not change body 
proportion or breast position, and cannot therefore be expected to relieve symptoms of 
breast hypertrophy [1].  The American Society of Plastic Surgeons states that despite the 
fact that weight reduction may be beneficial to the patient’s overall health, it is not a pre-
requisite for reduction mammaplasty surgery [1], a statement clearly being overlooked by 
insurance companies.   
Other forms of nonsurgical treatments have also been shown to not provide full 
relief of breast hypertrophy symptoms, and in some cases do not provide any relief.  
Orthotic brassieres have been shown to provide some relief, but often substitute increased 
discomfort in the shoulders through pressure created by the straps [1].  In the BRAVO 
study conducted by Kerrigan et al, patients presenting for surgery were asked to report 
any prior nonsurgical attempts to relieve their breast-related symptoms.  The four most 
common alternative treatments reported were weight loss, supportive bras, medications 
and physical therapy [28]. Of the women surveyed, less than 1% found full permanent 
relief with medications and heat applications and none reported full permanent relief with 
other nonsurgical treatments [1, 28].  Also, over half of those women who had tried 
several treatments, including weight loss, support bras, strengthening exercises and 
postural training, reported no relief from these treatments [1, 28].   
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Medical Coverage by Third Party Payers 
Despite increasing recognition of breast hypertrophy as a morbid condition, there 
is still great debate between plastic surgeons and insurance companies over when 
reduction mammaplasty is considered medically necessary and therefore eligible for 
insurance coverage.  One foreseeable issue with determining medical necessity is that the 
guidelines by which insurers determine eligibility for coverage of reduction 
mammaplasty rely largely on subjective materials [35].  As a result, the criterion 
insurance companies choose to use to determine coverage is often inconsistent resulting 
in decisions for coverage that are not always equitable.   
One criterion that is uniform across medical policies and consistent with the 
definition of cosmetic surgery provided by the American Society of Plastic Surgeons is 
that reduction mammaplasty will not be considered medically necessary when it is 
performed solely for the purpose of treating psychological and psychosocial complaints 
related to appearance [11, 31-33].  The American Society of Plastic Surgeons (ASPS) 
states that justification for reduction mammaplasty should be based on the probability of 
relieving the clinical signs and symptoms of macromastia.  The ASPS also recommends 
that coverage be based on documented symptoms of macromastia regardless of body 
weight or weight of breast tissue removed [36]. 
Regardless of the ASPS recommendations and documentation by the American 
Medical Association clearly defining the distinction between cosmetic and reconstructive 
procedures, many insurance companies apply various criteria of their own in determining 
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medical necessity.  Most commonly, insurance companies establish a minimal amount of 
breast tissue that must be removed in order to establish eligibility [1].  In a study done by 
Krieger et al it was reported that sixty-nine percent of responding managed-care 
organizations used weight of excised tissue as the primary criterion for coverage [37].  
A meta-analysis of published studies found that a cut-off value of 350 grams is 
one of the most common requirements for medical necessity by third-party payers [3].  
However, Kerrigan et al reported that most insurance carriers use a 500g/breast tissue as 
a cutoff irrespective of body habitus or patients’ presenting symptoms [20].  These 
differences in reported criteria for minimum amount of breast tissue to be removed 
support arguments by health care providers that using the weight of excised breast tissue 
as a primary criterion for establishing medical necessity is arbitrarily based on 
retrospective studies rather than scientific evidence. 
Many insurance companies use the Schnur Sliding Scale as a standard tool to 
determine medical necessity [3, 31, 32, 34, 38].  The Schnur sliding scale was developed 
by Schnur et al in 1991 as an attempt to create a decision rule about the medical necessity 
for reduction mammaplasty.  The scale proposes a “sliding” adjustment of required 
resection weight of breast tissue to be removed based on a woman’s body surface area 
[20].   
The logic behind the Schnur sliding scale comes from physician’s opinions on 
their patient’s motivation for surgery.  The scale proposes that when the amount of breast 
tissue to be removed compared to the woman’s body surface area lies above the 22nd 
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percentile line the patient’s motivations are mostly functional and it should be considered  
medically necessary for the patient to undergo reduction mammaplasty surgery.  
However, when the amount of tissue to be removed falls below the fifth percentile line, 
the model’s authors suggest that these women are seeking surgery for purely cosmetic 
reasons. The authors also propose that women who fall in between the two lines have a 
mixture of cosmetic and functional needs for the surgery and are considered on a case to 
case basis [20, 35].   
Despite the wide use of the Schnur sliding scale by insurance companies as a 
criterion to determine the medical necessity of reduction mammaplasty, the legitimacy of 
the scale has been questioned.  Seitchik questioned Schnur’s work stating that it cannot 
be assumed that patients registered below the fifth percentile were the same ones who 
undertook surgery for only cosmetic reasons [35].  Based on a retrospective study of his 
own patients, Seitchik concluded that a graded, three-level minimum specimen weight 
standard would be more equitable for determining medical necessity [35].  However the 
criteria developed in his study are much less restrictive than the 500g/breast minimum 
rule used as a cutoff by many insurance carriers.   
 As part of the BRAVO study conducted by Kerrigan et al, researchers 
investigated the scientific basis of both the Schnur sliding scale and the 500g/breast 
minimum rule established by insurance companies.  Findings from this study showed that 
in women undergoing reduction mammaplasty, neither the Schnur siding scale nor the 
500-g minimum rule was able to successfully predict which group of women would gain 
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greater improvement from surgery as measured by 5 validated measures of health burden 
[20].  As a result, Kerrigan et al concluded that the benefits of reduction mammaplasty 
are not significantly associated with weight of resection, and recommended that breast 
hypertrophy be defined by a breast volume in the top 10th percentile (>750cc) of the U.S. 
population or a minimum bra cup size D[20, 28]. 
Spector et al published a study in 2007 supporting findings from the BRAVO 
study that symptom improvement and patient satisfaction is independent of the amount of 
breast tissue removed.  In this study, patients were given a custom-designed questionnaire 
designed to evaluate breast-hypertrophy related symptoms and quality of life factors 
preoperatively and then given the same questionnaire at their final postoperative visit 
three to twelve months after surgery.  Results of this study showed that all 59 women 
who had resection weights of less than 1000g showed significant decreases in breast 
hypertrophy related symptoms analyzed including upper back pain, lower back pain, neck 
pain, breast pain, headaches and shoulder pain.  These same women also showed 
significant improvements in all quality of life factors analyzed including difficulty buying 
clothes and bras, difficulty participating in sports, and difficulty running [39].  Spector et 
al also did a second study on 188 patients in 2008 and found that prior to surgery, women 
have the same symptom burden across all breast sizes and that the symptomatic 
improvement derived from reduction mammaplasty is not significantly different between 
women with different breast sizes [40].    
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Summary 
In summary, the task of defining medical necessity in the case of reduction 
mammaplasty is complex.  Most women who suffer from breast hypertrophy present with 
similar physical and psychosocial symptoms and may also present with functional 
disabilities due to improper positioning of the head and scapula.  While there are many 
nonsurgical treatment options available to help reduce symptoms of breast hypertrophy 
reduction mammaplasty is the only treatment option shown to significantly improve 
symptoms of breast hypertrophy.  However, there is a lack of objective measurements 
providing evidence of the medical necessity of reduction mammaplasty to relieve 
symptoms of breast hypertrophy.  As a result, insurance companies are forced to make 
medical coverage decisions based on subjective evidence found in the medical literature. 
In an attempt to provide scientific evidence of the medical necessity of reduction 
mammaplasty to relieve symptoms of breast hypertrophy, the current study will 
investigate the musculoskeletal burdens of breast hypertrophy in women who do not 
present for reduction mammaplasty surgery.  It is theorized that women with larger 
breasts will exhibit both structural alterations and increased muscle activation due to the 
size and position of their breasts in comparison to women with smaller breast sizes. 
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METHODS 
This chapter addresses the methodology and procedures used to accomplish the 
objectives of this study.  Topics to be outlined in this chapter will include: mathematical 
definitions for all kinematic variables, equations for establishing local coordinate systems 
for each body segment of interest, equations and definitions of muscle activation, 
description of the health-measure instrument used, the experimental protocol, and the 
statistical methods used to evaluate the significance of the resulting data from this study. 
Kinematics 
Previous research has shown that breast hypertrophy causes postural alterations 
due to a change in the location of center of gravity [5,8].  Therefore, to fully understand 
the burdens of breast hypertrophy on the skeletal system, it was necessary to quantify the 
movements of the segments of the upper body during tasks of daily living.  Kinematic 
data of the upper body was tracked using a 6-camera optical motion camera system 
(Vicon, 250 HZ).  This system works by tracking the position of reflective spherical 
surface markers mounted on the skin surface.  For static calibration of the system, surface 
markers were placed on anatomical landmarks of the head, scapula, thorax, and pelvis 
(described below in anatomical surface marker section).  In addition, a solid triad of 
markers was placed on the scapula segment.  Simultaneous acquisition of coordinate 
systems for both the anatomically based landmarks of the scapula and the triad allowed 
for removal of the anatomical markers of the scapula during trials, and improved 
accuracy of the results. 
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Kinematic Model 
 Kinematics of the upper body were quantified using a four-segment model 
comprised of the head, scapula, thorax and pelvis.  Kinematic data was obtained in order 
to quantify movement in the head, thorax, pelvis, and scapula during each task of daily 
living.  Once this data is known, it can be compared to the same kinematic data for the 
static trials in order to get an idea of the biomechanics of the upper body used to perform 
each task of daily living.   
Anatomically Based Landmarks 
 Local coordinate systems for each segment were established by placing surface 
markers over at least three anatomically based landmarks in each segment.  The locations 
of the markers for the head, thorax, pelvis and scapula are as follows: 
 Head (Figure 1.) 
o Left front head (LFHD): Point of the left anterior side of the head 
o Right front head (RFHD): Point of the right anterior side of the head  
o Left back head (LBHD): Point of the left posterior side of the head 
o Right back head (RBHD): Point of the right posterior side of the head 
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Figure 1. Location of Head Markers  
 
 Thorax (Figure 2.) 
o Seventh Cervical Vertebrae (C7): Spinous process of the seventh cervical 
vertebrae 
o Sixth Thoracic Vertebrae (T6): Spinous process of the sixth thoracic 
vertebrae 
o Twelfth Thoracic Vertebrae (T12): Spinous process of the twelfth thoracic 
vertebrae 
LBHD 
LFHD 
RBHD 
RFHD 
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Figure 2.  Location of Thorax Markers  
 
 Pelvis (Figure3.) 
o Left Anterior Superior Iliac Spine (LASI): Anterior extremity of the iliac 
crest of the pelvis on the left side 
o Right Anterior Superior Iliac Spine (RASI): Anterior extremity of the iliac 
crest of the pelvis on the right side 
o Left Posterior Superior Iliac Spine (LPSI): Posterior extremity of the iliac 
crest of the pelvis on the left side 
o Right Posterior Superior Iliac Spine (RPSI): Posterior extremity of the 
iliac crest of the pelvis on the right side           
 C7 
 T6 
 T12 
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Figure 3. Location of Pelvic Markers (Inferior View) 
 
 Scapula (Figure 4.) 
o Trigonum Spine (TS):  Midpoint of the triangular surface on the middle 
border of the scapula, in line with the scapular spine 
o Angulus Acromialis (AA):  The most laterodorsal point of the scapula 
o Inferior Angle (AI):  The most caudal point of the scapula 
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TS 
AA 
AI 
 
Figure 4. Location of Scapula Markers (Posterior View) 
 
Local Coordinate Systems 
With at least three known anatomically based coordinates, a local coordinate 
system can be established for each body segment of interest.  The methods used to create 
local coordinate systems for the head, thorax, pelvis and scapula is described below. 
 Head (Figure 5):  The origin of the head coordinate system (H0) was located at the 
center of the head.  The location of H0 was calculated by calculating the midpoint 
of the line connecting the midpoint of the two anterior markers (LFHD and 
RFHD) and the two posterior markers (LBHD and RBHD) using the following 
equations:   
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o Midpoint (HF) of the two anterior markers (LFHD and RFHD) 
HF = (LFHD+RFHD)/2 
Equation 1. 
o Midpoint  (HB) of the two posterior markers (LBHD and RBHD) 
HB = (LBHD+RBHD)/2 
Equation 2. 
o Location of the origin (H0) 
H0 = (HF + HB)/2 
Equation 3. 
The x-axis (HX) of the head coordinate system was a unit vector pointing in the 
anterior direction from H0 to HF. 
HX = 
 
0
0
HH
HH
F
F

  
Equation 4. 
The z-axis (HZ) of the head coordinate system was a unit vector pointing in the 
superior direction and was the cross product of HX and a unit vector pointing from 
H0 to LFHD. 
HZ = 
 
 0
0
HLFHDH
HLFHDH
X
X

  
Equation 5. 
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Finally, the y-axis (HY) of the head coordinate system was a unit vector pointing 
to the left, and was the cross product of HZ and HX. 
HY = 
XZ
XZ
HH
HH

  
Equation 6. 
 
Figure 5.  Head Coordinate System 
 
 Thorax (Figure 6.):  The origin of the thorax coordinate system (T0) was located 
at the twelfth thoracic vertebrae (T12).  The z-axis (TZ) of the thorax coordinate 
system was a unit vector pointing in the superior direction from T0 to the seventh 
cervical vertebrae (C7). 
 
LBHD 
LFHD 
RBHD 
RFHD 
Ho 
HZ 
HY 
HXY 
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TZ = 
 
07
07
TC
TC

  
Equation 7. 
The y-axis (TY) of the thorax coordinate system was a unit vector pointing to the 
left and was the cross product of a unit vector pointing from C7 to T6 and TZ. 
TY = 
 
  Z
Z
TCT
TCT


76
76  
Equation 8. 
Finally, the x-axis of the thorax coordinate system was a unit vector pointing in 
the anterior direction and was the cross product of TY and TZ. 
TX =  
ZY
ZY
TT
TT

  
Equation 9. 
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Figure 6.  Thorax Coordinate System 
 Pelvis (Figure 7.):  The origin of the pelvic coordinate system (P0) was located at 
the center of the pelvis.  The location of P0 was calculated by calculating the 
midpoint of the line connecting the midpoint of the two anterior markers (LASI 
and RASI) and the two posterior markers (LPSI and RPSI) using the following 
equations:  
o Midpoint (MA) of the two anterior markers (LASI and RASI) 
MA = (LASI+RASI)/2 
Equation 10. 
o Midpoint  (MP) of the two posterior markers (LPSI and RPSI) 
 
 C7 
 T6 
 T12 
 
Tz 
TX 
TY 
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MP = (LPSI+RPSI)/2 
Equation 11. 
o Location of the origin (P0) 
P0 = (MA + MP)/2 
Equation 12. 
The x-axis (PX) of the pelvis coordinate system was a unit vector pointing in the 
anterior direction from P0 to MA. 
PX = 
 
0
0
PM
PM
A
A

  
Equation 13. 
The z-axis (PZ) of the pelvis coordinate system was a unit vector pointing in the 
superior direction and was the cross product of PX and a unit vector point from P0 
to LASI. 
PZ = 
 
 0
0
PLASIP
PLASIP
X
X

  
Equation 14. 
Finally, the y-axis (PY) of the pelvis coordinate system was a unit vector pointing 
to the left, and was the cross product of PZ and PX. 
PY = 
XZ
XZ
PP
PP

  
Equation 15. 
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Figure 7.  Pelvic Coordinate System 
 
 Scapula (Figure 10.):  As described earlier, a triad was placed on the scapula 
segment during data collection in order to better facilitate data collection of the 
scapular region.  Use of the triad required the establishment of a triad coordinate 
system.  A rotation matrix was used to align the triad coordinate system with the 
anatomical coordinate system for the scapula in order to calculate joint angles of 
the scapula during dynamic trials.  This allowed for the points of the scapula to be 
located during the dynamic trials even though the anatomical markers were not 
present.  Please refer to the diagram of the triad in Figure 8 for the following 
equations. 
LASI 
RPSI 
RASI 
LPSI 
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Figure 8.  Scapula Triad 
 
The y-axis of the triad coordinate system (TrY) was a unit vector pointing from T3 
to T1.  
TrY = 
 
31
31
TT
TT

  
Equation 16. 
The z-axis of the triad coordinate system (TrZ) was a unit vector pointing in the 
superior direction perpendicular to the plane formed by triad markers T1, T2, and 
T3.  This was found by taking the cross product of TrY and a unit vector pointing 
from triad marker T3 to triad marker T2. 
TrZ = 
 
 32
32
TTTr
TTTr
Y
Y

  
Equation 17. 
Finally, the x-axis of the triad coordinate system (TrX) was a unit vector pointing 
in the anterior direction and was the cross product of TrY and TrZ. 
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TrX =  
ZY
ZY
TrTr
TrTr

  
Equation 18. 
 
Figure 9.  Triad Coordinate System 
 
The first step in aligning the triad coordinate system with the anatomical 
coordinate system of the scapula was to establish the unit vector matrix for the 
triad [UTRI]. 
 [UTRI] = [TrX´  TrY´  TrZ´] 
Equation 19. 
Next, the scapula anatomical markers were located using data from the static trial.  
Anatomical marker offsets for AA, TS, and AI (S1, S2, and S3, respectively) 
represent the distance from the anatomical marker to the origin of the triad (T2).  
Once these anatomical markers were located, they were then rotated into the 
global coordinate system (UG). 
 
TrY 
TrX 
TrZ 
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o Location of AA 
AA =    12 SUUT TRIG   
Equation 20. 
o Location of TS 
TS =    22 SUUT TRIG   
Equation 21. 
o Location of AI 
AI =    32 SUUT TRIG   
Equation 22. 
Based on data from the triad (see equations 20-22) a new scapula coordinate 
system was created with its origin at AA.  The y-axis of the scapula coordinate 
system (SY) was a unit vector pointing from AA to TS. 
SY = 
 
AATS
AATS

  
Equation 23. 
The x-axis of the scapula coordinate system (SX) was a unit vector pointing in the 
anterior direction and perpendicular to the plane formed by scapula markers AA, 
TS, and AI.  This was found by taking the cross product of a unit vector pointing 
from AA to AI and SY . 
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SX = 
 
  Y
Y
SAAAI
SAAAI

  
Equation 24. 
Finally, the z-axis of the scapula coordinate system (SZ) was a unit vector 
pointing in the superior direction and was the cross product of SX and SY. 
SZ =  
YX
YX
SS
SS

  
Equation 25. 
 
Figure 10.  Scapula Coordinate System 
 
•AA-Angulus Acromialis 
•TS-Trigonum Spinae 
•AI-Angulus Inferior 
 
Sz 
Sx 
 Sy  
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Rotation Sequences for Each Body Segment 
In order to calculate the segment angles of interest, rotation matrices for each 
segment were created. 
 Head rotation matrix 
[RH] = [HX´  HY´  HZ´] 
Equation 26. 
 Thorax rotation matrix 
[RT] = [TX´  TY´  TZ´] 
Equation 27. 
 
 Pelvis rotation matrix 
[RP] = [PX´  PY´  PZ´] 
Equation 28. 
 Scapula rotation matrix 
[RS] = [SX´  SY´  SZ´] 
Equation 29. 
Euler angles were then calculated in order to quantify the orientation of one 
segment relative to another segment.  The orientation of the pelvis (RPelvis) was defined 
relative to the global coordinate system and was the product of the inverse of the pelvis 
rotation matrix [RP] and the global coordinate system matrix [UG ]. 
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RPelvis =    GP URinv   
Equation 30. 
The orientation of the torso (RTorso) was defined relative to the pelvis (RPelvis) and was the 
product of the inverse of the torso rotation matric [RT] and the pelvis rotation matrix [RP]. 
RTorsos =    PT RRinv   
Equation 31. 
The orientation of the scapula (RScap) was defined relative to the torso (RTorso) and was the 
product of the inverse of the scapula rotation matrix [RS] and the torso rotation matrix 
[RT]. 
RScap =    TS RRinv   
Equation 32. 
Finally, the orientation of the head (RHead) was defined relative to the torso (RTorso) and 
was the product of the inverse of the head rotation matrix [RH] and torso rotation matrix 
[RT]. 
RHead =    TH RRinv   
Equation 33. 
In this study, the sagittal plane was the primary plane of movement (movement 
about the y-axis).  Therefore, rotations were conducted in the following order to ensure 
accuracy in the calculations of movement occurring in the sagittal plane:  Y-axis, X-axis, 
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Z-axis.  Euler angles for each segment were extracted from the unit vector matrix 
associated with that segment using the following equations 
 Movement about the Y-axis 





 
 
33
321tan
R
R
  
Equation 34. 
 Movement about the X-axis 
 311sin R  
Equation 35. 
 Movement about the Z-axis 





 
 
11
211tan
R
R
  
Equation 36. 
  
For the head and thorax α, β, and γ correspond to flexion/extension, lateral 
flexion, and rotation, respectively.  For the pelvis, α, β, and γ correspond to tilt, lateral 
flexion and internal/external rotation, respectively.  For the scapula, α, β, and γ 
correspond to tilt, upward rotation, and protraction/retraction, respectively. 
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Electromyography 
Postural alterations due to heavy breast tissue may cause strain on the cervico-
thoracic muscles, thus inducing muscle weakness of these important upper body postural 
muscles.  In order to examine the effects of excess breast tissue mass on cervico-thoracic 
muscle activation, electromyographic data of the muscles associated with 
musculoskeletal pain in the neck, back and shoulder regions was obtained using a 
wireless surface electromyography (sEMG) system (BTS Engineering FreeEMG, 1000 
Hz).  This system works by using wireless technology to detect muscle activation via 
individual sensors placed over the muscle of interest.  This section will address the 
placement of the electrodes, processing of the raw signals, and the quantification of the 
amplitude of muscle activation for all five muscles of interest as a percentage of MVC. 
Electrode Placement 
Prior to placement of individual EMG sensors on the subject, the subject’s skin 
was abraded and cleaned with alcohol in order to reduce skin impedance.  Pre-gelled 
silver-silver chloride bipolar electrodes with the wireless EMG sensors attached were 
then placed on each of the five muscles of interest according to the methods described by 
Cram (Table 1 below and Figures B1-B5 in Appendix B) [41].    
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Table 1.  Surface Electrode Placement 
 
Muscle Placement 
Midcervical (C-
4) Paraspinal 
Placed two centimeters away from the spine and parallel with the 
muscle fibers over the muscle belly at approximately the fourth 
cervical vertebrae (C-4) 
 
Upper 
Trapezius 
Placed running parallel with the muscle fibers along the ridge of the 
shoulder, slightly lateral to and onehalf the distance between the 
seventh cervical vertebrae (C-7) and the acromion 
Lower 
Trapezius 
Placed at an oblique angle, approximately five centimeters down 
from the scapular spine and placed next to the medial edge of the 
scapula at a 55-degree angle 
Serratus 
Anterior 
Placed horizontally just below the axillary area, at the level of the 
inferior tip of the scapula, and just medial of the latissimus dorsi. 
Low Back 
(Erector Spinae) 
Placed parallel to the spine, approximately two centimeters from the 
spine and placed over the muscle mass.  Subjects were in a slight 
forward flexion for electrode placement.  
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Maximum Voluntary Contraction Protocol 
To define the maximal exertion of the muscles of interest, a maximum voluntary 
contraction (MVC) was obtained for each muscle.  The exercise chosen to obtain the 
MVC for each muscle of interest was the superman exercise, in which the chest, arms, 
and legs are simultaneously raised as high off the table as possible (Figure 11). 
Each subject was instructed to lie in a prone position on an examination table with her 
arms stretched out in front.  The subject was then strapped to the table with one strap 
across the top of the shoulders and a second strap just above the knees in order to provide 
resistance to the subject during the exercise.  Each subject performed five repetitions of 
the MVC and the average maximum EMG signal during the contraction was used to 
normalize the tasks of daily living EMG signals. 
 
Figure 11.  The Superman Exercise  
 
Initial Signal Processing 
EMG data was obtained via surface electromyography.  EMG signals from each 
muscle were sampled at 1000 Hz via individual EMG sensors placed over the muscles of 
the neck, upper thorax, and low back (described above in Table 1) during each activity of 
daily living (described below in the experimental protocol section).  Data was rectified 
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and smoothed using a root mean square algorithm with a 20-ms moving window and 
normalized to the MVC as a percentage of effort.   
To find the percent muscle activation of each of the five muscles of interest, the 
peak EMG signal for each muscle was found using custom Matlab software.  This 
maximum peak was used to establish a ratio of upper body posture muscle activation to 
MVC muscle activation, resulting in a ratio of percent effort ranging from 0-100%. 
% Muscle Activation = 100





muscle
muscle
MVC
A  
Equation 37. 
In the above equation, Amuscle represents the peak amplitude of the individual muscle 
activation during each task of daily living, and MVCmuscle represents the peak amplitude 
of the individual muscle activations during the MVC exercise. 
Health-Related Quality of Life 
Women who present with breast hypertrophy typically exhibit poorer scores on 
health-related quality of life instruments [2, 14, 21, 28, 29].  Although the main focus of 
this study is the biomechanical effects of breast hypertrophy on the spine and cervico-
thoracic muscle activation, it was important to assess each subject’s health-related quality 
of life status in order to establish relationships between the biomechanical data from this 
study and the health-related quality of life data presented in previous studies. 
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Health-Measure Instrument  
The Breast Related Symptoms Questionnaire (BRSQ) was administered to each 
subject in order to determine the severity of the pain associated with breast hypertrophy 
each subject is experiencing (See Appendix A).  The BRSQ is a 13 item condition 
specific instrument developed by Kerrigan et al in 2001 in order to systematically 
quantify breast-specific symptoms [21].  A breast symptom summary score (BSS) was 
computed by averaging the item scores and linearly transforming the average to a 0-to-
100 scale.  For this instrument, higher summary scores correspond to fewer and less 
severe systems.  This instrument has undergone test-retest reliability and has face validity 
[20, 21].  
Experimental Protocol 
All subjects for this study were women over the age of 18 who have never 
undergone or been approved for breast augmentation surgery (N=26).  All subjects were 
recruited from the general student, faculty and staff population at Boise State University.  
Participation in this study was strictly voluntary, and subjects were free to discontinue 
their participation in this study at any time during the data collection session.  This study 
was approved by the Institutional Review Board at Boise State University prior to 
initiation of subject recruitment.   
All testing was conducted at the Intermountain Orthopaedics Sports Medicine and 
Biomechanics Research Laboratory on the campus of Boise State University in Boise, 
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Idaho.  Upon arrival to the lab, each subject read and signed the informed consent 
document prior to participation in the study and was given a copy for their records.    
Once the informed consent had been signed, each subject completed the Breast 
Related Symptoms Questionnaire.  Subjects were allowed to fill out this questionnaire 
independently with the principal investigator present in order to answer any questions 
that the subject may have had.   
Following completion of the Breast Related Symptoms Questionnaire, descriptive 
data for each subject was obtained for each individual by the principal investigator and a 
research assistant. The data obtained included: age, height, weight, self-reported bra cup 
size, type of bra worn for testing, and sternal notch to nipple distance.  Each subject’s 
height (meters) and weight (kilograms) was used to calculate her Body Mass Index 
(BMI) using the following formula: 
 
BMI = 2)(
)(
mheight
kgweight  
Equation 38. 
Once all the descriptive data had been obtained, each subject was prepared with 
spherical surface markers and EMG electrodes for biomechanical data collection (as 
described above in kinematic and muscle activation section, respectively).  Subjects were 
asked to perform testing while wearing a tank top so that surface markers and sEMG 
electrodes could be placed directly on the skin surface when appropriate (See Appendix 
C for pictures of complete subject setup).  Once all the surface markers and sEMG 
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electrodes were in place, a static image of the subject was obtained using the VICON 
optical motion capture system.   Once the static image was obtained, the anatomically 
based markers on the scapula were removed (as described above in the Kinematics 
section and seen below in Figures 12 and 13). 
 
Figure 12.  Scapula Marker Set up during the Static Image 
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Figure 13.  Anatomically Based Scapula Markers Removed 
 
In order to get an idea of the kinematics of the upper body and the amount of 
muscle activation each subject used while in their natural standing postural alignment, 
static posture measurements were obtained before and after the four tasks of daily living 
had been completed.  To obtain static posture, subjects were instructed to place their 
hands on their hips and adopt a comfortable and natural standing position as if no one 
was watching them [25].  Once in this position subjects were instructed to remain as still 
as possible and to count backwards from fifty.  Static positions of each of the surface 
markers, and static values for muscle activation were captured for two 3-5 second 
intervals both before and after the four tasks of daily living had been completed (Figure 
14).  
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Figure 14.  Standing Position of Subject during Static Posture Measurements 
 
Kinematics of the upper body as well as muscle activation was measured while 
the subject performed four different tasks of daily living.  Each subject performed a series 
of 5-10 trials of each of the four tasks of daily living with approximately 30-45 seconds 
of rest in between each trial and 1-2 minutes of rest between each task.   The tasks were 
performed in random order and included:  
 Picking a pencil off the ground:  Subjects were instructed to begin the exercise 
with their hands on their hips and reach down to pick up a pencil off the floor as 
they normally would as if they had dropped it.  Subjects were also instructed to 
place their hands back on their hips following the completion of the task.  
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 Sitting down and standing up from a stool:  Subjects were asked to place their 
hands on their hips throughout the duration of the task as they sat down and then 
stood up from a stool. 
  Stepping on and off a six inch tall platform:  Subjects were instructed to step on 
and off the platform leading with their right leg and keeping their hands on their 
hips throughout the duration of the task. 
 Lifting a milk jug filled with 9.75 pounds of sand overhead:  Subjects were 
instructed to begin the exercise with their hands on their hips, and then reach 
down and pick up the weighted milk jug with their right hand.  Once they had 
picked up the jug, each subject used their left hand to help guide the jug to a point 
overhead, and then lowered the jug back down.  Subjects were also instructed to 
place their hands back on their hips following the completion of the exercise. 
Once all the trials had been completed, the electrodes and surface markers were removed 
by the principal investigator and research assistants. 
Statistics 
All statistical analysis was completed using Microsoft Excel 2003 for Windows.    
To compare muscle activation and kinematic variables across the four tasks of daily 
living, and BSS scores between subjects, a two-tailed independent t-test was performed 
for each dependent variable of interest.  Power analysis was performed for each 
dependent variable’s t-test using an online statistics toolkit (provided by DSS Research) 
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in order to get an idea of the probability of making a type II error (β).  For the purposes of 
this study, p values less than 0.05 were considered to be statistically significant.    
Due to the small size of the subject population and the possibility of slight 
variations in how each subject chose to perform each task of daily living, an outlier test 
was performed on all data collected in order to account for any extreme skews in the 
distribution.  In order to identify possible outliers in the data set, the interquartile range 
(IQR) was computed for each dependent variable. Data points found to be three times the 
IQR less than the first quartile or three times the IQR greater than the third quartile were 
considered outliers and were not included in the final data analysis.   Data points 
associated with muscle activation were also excluded from the final data if %MVC 
values during tasks of daily living produced negative results since that would indicate 
that the subject used greater than their maximum effort to complete the given task.   
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RESULTS 
This section contains all the results from the data collection and analysis 
previously described.  This includes demographic information of the participating 
subjects and comparison of breast summary scores (BSS), muscle activation and upper 
body kinematics between normal control subjects and breast hypertrophy subjects.  A 
total of 26 subjects participated in this study.  However, only 22 subjects were used in the 
final analysis due to insufficient data from four participants.  All subjects were recruited 
from the female population of students and faculty at Boise State University and had no 
history of breast augmentation surgery. 
Three subjects from the normal control group were not included in the lift trial 
results and one subject from the normal control group was not included in the step up trial 
results because the electromyography data did not match up with the kinematic data.  As 
a result, the normal control group data set consisted of 608 data points and the 
hypertrophy group data set consisted of 540 data points before statistical analysis took 
place.   
As mentioned above in the methods section, any negative %MVC values and 
extreme outliers were removed from the data sets.  Out of 608 data points for the normal 
group, fourteen data points were removed for being negative %MVC values and fifteen 
data points were removed for being extreme outliers for a total of 4.76% of points 
removed from the normal control group data set.  Out of 540 data points for the 
hypertrophy group, twelve data points were removed for being negative %MVC values, 
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and fifteen data points were removed for being extreme outliers for a total of 5.00% of 
points removed from the hypertophy group data set.    
Demographics 
Of the 22 subjects analyzed, 12 were in the normal control group (self-reported 
bra cup sizes A – C), and 10 were in the hypertrophy group (self-reported bra cup size > 
D).  Distribution of self-reported bra cup sizes is shown in Figure 15.  The average age of 
the normal control and hypertrophy subjects was 24.4 (±4.1 yrs, range 20-34), and 26.1 
(±6.7 yrs, range 21-40), respectively.   
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Figure 15.  Subject Distribution by Group and Bra Cup Size 
Subject demographics for the two groups are given in Table 2.  Statistical analysis 
of the subject demographics revealed significant differences in height (p=0.003), BMI 
(p=0.009), left SNTND (p=0.004), and right SNTND (p=0.000) between the two groups. 
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Table 2.  Subject Demographics 
 
  
Normal 
Control Hypertrophy p value Power 
Mean 1.73 1.64 Height 
(m) Std Dev 
±0.10 ±0.44 0.003* 0.778 
Mean 71.00 77.60 Weight 
(kg) Std Dev 
±10.0 ±11.34 0.322 0.299 
Mean 23.92 28.84 BMI 
(kg/m2) Std Dev 
±3.62 ±3.78 0.009* 0.873 
Mean 15.23 18.65 Left 
SNTND Std Dev 
±1.23 ±2.60 0.004* 0.968 
Mean 14.75 18.36 Right 
SNTND Std Dev 
±1.11 ±2.41 0.005* 0.992 
*Statistically significant p<0.05 
 
BRSQ Scores 
The Breast Related Symptoms Questionnaire (BRSQ) is a validated instrument 
used to evaluate the severity of breast-related symptoms.  The BSS is a linearly 
transformed average of the responses given on the BRSQ, and is used to quantify the 
burdens of breast hypertrophy with lower scores being indicative of an increase in the 
severity of breast-related symptoms.  Data from the BRSQ for both subject groups is 
shown in Table 3.  Women in the normal control group scored significantly higher 
(p=0.005) on the BRSQ, indicating a lesser severity of breast-related symptoms. 
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Table 3.  BRSQ Scores 
 
Group BSS 
Standard 
Deviation Power 
Normal 
Control 99.13 1.32 
Hypertrophy 71.54 19.75 
0.993 
*Statistically significant p<0.05 
    
Kinematic Results 
 Upper body kinematics of the head, thorax, pelvis and scapula were quantified in 
order to get a better understanding of the effect of breast size on the musculoskeletal 
system.  Specifically, head flexion, torso flexion and extension, lateral torso extension, 
scapular protraction, scapular upward rotation, and pelvic tilt were analyzed for static 
trials and for each task of daily living.   
For analysis purposes, two static trials from the beginning of the data collection 
and two static trials from the end of the data collection were used to create an “average 
static posture” for each subject.  Subject movement was normalized to static posture by 
subtracting the “average static posture” from the average maximum kinematic values for 
each task, thus allowing movement variables between subjects to be compared.   
Static Posture  
Static trial data was collected before and after the four tasks of daily living had 
been completed.  Group averages of average static posture measurements for normal 
control subjects and hypertrophy subjects are shown in Figure 16.   
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Figure 16.  Group Average Static Posture Variables 
Average static posture values for both groups are shown in Table 4.  Statistical 
analysis revealed no significant differences in average static posture between groups.  
However, it is important to note that anterior pelvic tilt is approaching significance 
(p=0.098) during static posture measurements. 
Table 4.  Average Static Posture 
Group 
Head 
Flexion (+) 
Anterior 
Pelvic 
Tilt (+) 
Scapular 
Protraction 
(+) 
Scapular 
upward 
rotation 
(+)  
Torso 
flexion 
(+) 
Mean 13.87º 5.95 º 31.58 º 16.10 º 9.64º 
Normal 
Control 
Std 
Dev ± 7.45 º ± 4.19 º ± 13.85º ± 27.18 º ± 4.63º 
Mean 15.63 º 11.51 º  23.94 º 8.85º 13.85º 
Hypertrophy 
Std 
Dev ± 5.70 º ± 7.73 º ± 11.74º ± 21.23 º ± 8.04º 
p-value 0.839 0.097 0.13 0.354 0.23 
Power 0.097 0.532 0.288 0.108 0.311 
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Head Flexion 
Head flexion data for the pencil, sit, step up, and lift tasks for both normal control 
and hypertrophy subjects are shown in Table 5.  Normal control subjects appear to 
present with more head flexion while performing tasks of daily living.  However, 
statistical analysis provided no significant differences between the two groups during 
these tasks. 
Table 5.  Head Flexion During Tasks of Daily Living 
Task   
Normal 
Control Hypertrophy p value Power 
Mean 35.70º 30.18º 
Pencil Std 
Dev ±11.16º ±9.32º 
0.484 0.244 
Mean 20.48º 15.11º Sit 
Std Dev ±6.55º ±12.17º 
0.206 0.240 
Mean 5.29º 4.59º Step Up 
Std Dev ±7.21º ±4.81º 
0.741 0.059 
Mean 26.18º 16.21º Lift 
Std Dev ±14.02º ±7.13º 
0.325 0.576 
  
Pelvic Tilt 
Data regarding the average amount of pelvic tilt occurring during the four tasks of 
daily living is provided in Table 6.  For 3 of the 4 activities of daily living, hypertrophy 
subjects appear to present with more anterior pelvic tilt.  Despite visual differences, 
statistical analysis showed no significant differences between the two groups during the 
four tasks of daily living.  However, the difference in pelvic tilt during the sit exercise 
appears to be approaching significance (p = 0.091).   
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Table 6.  Pelvic Tilt During Tasks of Daily Living 
Task   
Normal 
Control Hypertrophy p value Power 
Mean 27.18º 28.27º Pencil 
Std Dev ±3.30º ±12.15º 
0.296 0.059 
Mean 11.59º 17.11º Sit 
Std Dev ±6.10º ±7.74º 0.091 0.449 
Mean 8.01º 10.63º Step Up 
Std Dev ±3.09º ±4.90º 0.123 0.311 
Mean 8.82º 6.29º Lift 
Std Dev ±4.12º ±6.92º 0.527 0.174 
 
Scapular Movements 
 The main movement of interest for the scapula was scapular protraction, except 
for in the lift task in which upward rotation of the scapula was examined.  Data for the 
scapula movement during the four tasks of daily living is provided in Table 7.  Statistical 
analysis of the movements of the scapula during all four tasks of daily living showed no 
significant differences between the normal control group and the hypertrophy group. 
Table 7.  Scapula Movement During Tasks of Daily Living 
 
Task   
Normal 
Control Hypertrophy p value Power 
Mean 22.99º 22.15º Pencil 
Std Dev ±15.99º ±24.30º 
0.914 0.051 
Mean 6.22º 8.40º Sit Std Dev ±7.70º ±4.87º 0.317 0.057 
Mean 10.19º 8.09º Step Up Std Dev ±7.93º ±5.39º 0.545 0.114 
Mean 7.21º 4.53º Lift# Std Dev ±7.03º ±4.09º 0.450 0.199 
#Scapular Upward Rotation measured during lift trials 
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Torso Flexion 
 Torso flexion was analyzed across all four tasks of daily living, except for in the 
lift task which torso extension was the variable of interest.  During the lift task, lateral 
torso flexion (Lift 2) was also analyzed in order to investigate the role of the spine in the 
biomechanics of the shoulder during an overhead activity (positive values represent 
flexion of the spine towards the left side of the body).  Average torso flexion values for 
both subject groups during the four tasks of daily living are shown in Table 8.  Visual 
analysis of the data indicates that normal control subjects exhibited greater amounts of 
torso flexion during pencil, sit, and step up tasks.  Statistical analysis of torso flexion 
showed significant differences in the average amount of torso flexion during the pencil 
and step up tasks (p= 0.055 and 0.001, respectively).  Conversely, hypertrophy subjects 
exhibited slightly greater mounts of torso extension and lateral torso flexion during the 
lift tasks.  However, neither of these differences seen was statistically significant. 
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Table 8.  Torso Movement During Tasks of Daily Living 
Task   
Normal 
Control Hypertrophy p value Power 
Mean 53.40º 40.76º Pencil 
Std Dev ±10.87º ±13.25º 
0.055* 0.675 
Mean 19.31º 14.87º Sit 
Std Dev ±7.71º ±9.40º 
0.093 0.223 
Mean 15.21º 6.04º Step Up 
Std Dev ±4.72º ±4.99º 
0.001* 0.993 
Mean 6.12º 10.14º Lift# 
Std Dev ±3.11º ±7.59º 
0.190 0.349 
Mean 1.84º 1.88º Lift 2## 
Std Dev ±1.62º ±1.91º 
0.410 0.050 
#Values represent amount of torso extension during lift trials 
##Values represent lateral torso flexion during lift trials 
*Statistically significant p<0.05 
 
Muscle Activation 
 The amount of muscle activation (expressed as %MVC) exhibited by a particular 
muscle provides information about the amount of work the muscle of interest is 
performing.  It has been hypothesized that pain in the neck, back and shoulders 
symptomatic of breast hypertrophy may be due to increased tension (activation) of the 
cervico-thoracic muscles.   
This study specifically examined muscle activation of the Midcervical (C-4) 
paraspinal, upper trapezius, lower trapezius, serratus anterior, and the low back (Erector 
Spinae) during static posture trials and tasks of daily living.  All electromyography data 
matches up with the movement trials used in the kinematic analysis.  
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For analysis purposes, two static trials from the beginning of the data collection 
and two static trials from the end of the data collection were used to create “average static 
muscle activation” for each subject.  Subject movement was normalized to static posture 
by subtracting the “average static muscle activation” from the average muscle activation 
values for each task, thus muscle activation between subjects to be compared.   
Static Posture 
Data was collected for static trials before and after the tasks of daily living were 
completed.  The muscle activation of the five muscles of interest during static posture 
trials is shown in Table 9.  Group averages of average static posture measurements for 
normal control subjects and hypertrophy subjects are shown in Figure 17.   
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Figure 17.  Group Averages for Muscle Activation 
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Table 9.  Static Muscle Activation 
Muscle   
Normal 
Control 
(%MVC) 
Hypertrophy 
(%MVC) p value Power 
Mean 6.10% 7.62% Midcervical Std Dev ±4.03% ±3.30% 0.582 0.170 
Mean 5.23% 13.04% Upper Trapezius Std Dev ±3.11% ±14.03% 
0.123 0.407 
Mean 3.12% 6.35% Lower Trapezius Std Dev ±1.39% ±5.04% 
0.051* 0.502 
Mean 6.64% 9.23% Serratus Anterior Std Dev ±3.39% ±5.00% 
0.075 0.286 
Mean 6.52% 10.62% Erector Spinae Std Dev ±3.90% ±4.86% 
0.115 0.576 
*Statistically significant p<0.05 
 
Analysis of static muscle activation shows that hypertrophy subjects exhibited 
higher percentages of muscle activation during static posture trials.  Statistical analysis 
indicates a significant difference in the level of muscle activation of the lower trapezius 
(p = 0.051). 
Pencil Task 
 Average muscle activation values for the pencil task are shown in Table 10.  
Hypertrophy subjects exhibited greater amounts of muscle activation for all five muscles 
during the pencil task.  However, statistical analysis showed no significant differences in 
the levels of muscle activation between the two subject groups during this task.  
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However, the difference in lower trapezius muscle activation between groups appears to 
be approaching significance.   
Table 10.  Muscle Activation during the Pencil Task 
Muscle   
Normal 
Control 
(%MVC) 
Hypertrophy 
(%MVC) p value Power 
Mean 3.12% 7.91% Midcervical Std Dev ±1.85% ±9.08% 0.168 0.375 
Mean 8.94% 12.75% Upper Trapezius Std Dev ±9.88% ±16.73% 
0.741 0.097 
Mean 2.54% 3.24% Lower Trapezius Std Dev ±2.59% ±3.40% 
0.071 0.083 
Mean 2.50% 3.39% Serratus Anterior Std Dev ±2.81% ±2.21% 
0.765 0.132 
Mean 2.04% 2.35% Erector Spinae Std Dev ±1.09% ±2.08% 
0.687 0.071 
*Statistically significant p<0.05 
 
Sit Task  
 Muscle activation levels of the five muscles of interest during the sit task are 
provided in Table 11.  Hypertrophy subjects exhibited greater muscle activation in all 
muscles except the upper trapezius during the sit task.  However, statistical analysis 
revealed no significant differences between the %MVC means of the normal control and 
hypertrophy group for this task. 
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Table 11. Muscle Activation during the Sit Task 
Muscle   
Normal 
Control 
(%MVC) 
Hypertrophy 
(%MVC) p value Power 
Mean 3.20% 3.39% Midcervical Std Dev ±3.25% ±2.71% 0.738 0.053 
Mean 5.75% 2.97% Upper Trapezius Std Dev ±5.43% ±2.06% 
0.114 0.373 
Mean 0.91% 1.24% Lower Trapezius Std Dev ±0.57% ±0.53% 
0.578 0.290 
Mean 2.71% 4.37% Serratus Anterior Std Dev ±2.63% ±3.45% 
0.426 0.239 
Mean 1.24% 1.64% Erector Spinae Std Dev ±0.55% ±0.76% 
0.410 0.284 
*Statistically significant p<0.05 
 
Step Up 
Muscle activation levels of the five muscles of interest during the step up task are 
provided in Table 12.  Hypertrophy subjects exhibited greater levels of muscle activation 
in the midcervical, lower trapezius, serratus anterior, and erector spinae during the step 
up task.  However, statistical analysis yielded no significant differences between the 
%MVC means of the normal control and hypertrophy groups for this task.   
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Table 12.  Muscle Activation during the Step Up Task 
Muscle   
Normal 
Control 
(%MVC) 
Hypertrophy 
(%MVC) p value Power 
Mean 4.42% 5.95% Midcervical 
Std Dev ±4.36% ±5.11% 
0.815 0.116 
Mean 5.12% 2.46% Upper Trapezius Std Dev ±3.09% ±0.95% 
0.139 0.776 
Mean 0.96% 5.94% Lower Trapezius Std Dev ±0.55% ±0.55% 
0.104 0.544 
Mean 3.75% 3.95% Serratus Anterior Std Dev ±2.44% ±2.74% 
0.577 0.054 
Mean 1.99% 3.72% Erector Spinae Std Dev ±1.00% ±2.33% 
0.239 0.589 
*Statistically significant p<0.05 
 
Lift Task 
Muscle activation levels of the five muscles of interest during the step up task are 
provided in Table 13. Statistical analysis of the muscle activation levels during the lift 
task showed no significant differences between the two groups.  However, it is important 
to note that hypertrophy subjects exhibited greater muscle activation in the lower 
trapezius, serratus anterior and erector spinae than the normal control subjects while 
performing this task 
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Table 13.  Muscle Activation during the Lift Task 
Muscle   
Normal 
Control 
(%MVC) 
Hypertrophy 
(%MVC) p value Power 
Mean 8.62% 6.65% Midcervical Std Dev ±4.72% ±4.92% 0.315 0.175 
Mean 27.57% 16.27% Upper Trapezius Std Dev ±26.19% ±13.86% 
0.241 0.253 
Mean 3.32% 5.12% Lower Trapezius Std Dev ±1.96% ±6.37% 
0.365 0.139 
Mean 4.69% 6.33% Serratus Anterior Std Dev ±2.80% ±4.70% 
0.590 0.163 
Mean 4.79% 5.22% Erector Spinae Std Dev ±2.86% ±4.30% 
0.481 0.058 
*Statistically significant p<0.05 
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DISCUSSION 
 The purpose of this study was to investigate biomechanical differences in the 
upper body of women with larger breast sizes in order to provide evidence of the 
musculoskeletal burdens of breast hypertrophy.  In this study, women were divided into 
two groups based on self-reported bra cup size in order to investigate differences in 
breast-related symptoms, and differences in upper body kinematics and muscle activation 
during tasks of daily living. 
BRSQ Scores 
While there is not an exact definition of breast hypertrophy, it is widely accepted 
as a characterized increase in the volume and weight of breast tissue beyond normal 
proportions.   Normal breast size is defined as a self-reported bra cup size of C or smaller 
[1, 20].  Previous studies have concluded that women who present with breast 
hypertrophy typically exhibit poorer scores on health-related quality of life instruments 
[2, 14, 21, 28, 29].   
Results from the analysis of the BRSQ in this study found that women in the 
normal control group (defined as self-reported bra cup size of C or smaller) scored 
significantly higher on the BRSQ than women in the hypertrophy group, indicating lesser 
severity of breast related symptoms.  These results are consistent with results from the 
BRAVO study by Kerrigan et al in which it was found that only 2% of women with 
normal breast sizes experience 2 or more breast related symptoms all or most of the time, 
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and 87.6% of women presenting for surgical correction of breast hypertrophy list at least 
two out of seven physical symptoms occurring all or most of the time [1, 20]. 
 Static Posture 
Women with breast hypertrophy generally present with numerous breast related 
symptoms relating to the skeletal system including neck strain, headache, and aching 
shoulders [8].  It is postulated that these symptoms are a direct result of functional 
impairment caused on the musculoskeletal system due to size and position of 
hypertrophic breasts.  However, examination of average static postures for the two 
subject groups in this study showed no significant differences in the skeletal alignment of 
the individuals in these groups.   
Despite a lack of significant differences in static posture alignment found in this 
study, it is important to note that the hypertrophy group did present with greater amounts 
of cervical lordosis (head flexion), forward shoulder position (shoulder protraction), 
thoracic kyphosis (torso flexion) and lumbar lordosis (pelvic tilt) than women in the 
normal control group.  These findings are supported by postulations by Letterman et al 
about the structural basis for breast related symptoms related to the skeletal system in 
which it is stated that the above structural changes are a direct result of a change in the 
body’s center of gravity to compensate for the weight and position of hypertrophic 
breasts [8]. 
Of increasing interest is the approaching significance of the difference in the 
degree of anterior pelvic tilt during the static condition.  Women in the hypertrophy 
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group demonstrated values of pelvic tilt almost double the value of women in the normal 
control group.  Increases in anterior pelvic tilt lead to an increase in lumbar lordosis [42].  
This increase in lumbar lordosis in the hypertrophy group is consistent to postulations by 
Letterman et al in which it was stated that increased lumbar lordosis is a compensatory 
mechanism used by women with breast hypertrophy to help keep the body in an upright 
position [8].   
Kinematics during Tasks of Daily Living 
Changes in the body’s center of gravity may lead to secondary effects on the 
functional mobility of the musculoskeletal system.  However, results from this study 
demonstrated few significant differences in the musculoskeletal mechanics of women 
with large breasts when compared to women with normal breast sizes.  Torso flexion 
exhibited the most consistent differences between the two subject populations, with 
normal control subjects exhibiting significantly increased torso flexion during the step up 
task, as well as increased torso flexion during the pencil and sit tasks.  These results are 
inconsistent with findings in static posture trials where women with hypertrophic breasts 
exhibited increased (although not significant) torso flexion, indicating that women with 
hypertrophic breasts may compensate for baseline alterations of the spine in other ways, 
such as increases in muscle activation, while performing tasks of daily living.   
Muscle Activation during Tasks of Daily Living 
Interestingly, these kinematic differences seen in the torso of normal control 
subjects were not accompanied by significant differences in muscle activation.  Despite 
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having increased torso flexion during pencil, step up, and sit tasks, normal control 
subjects had muscle activation values less than or similar to the muscle activation values 
for the women with breast hypertrophy during the same tasks.   
The pencil task was the only activity that provided a difference in muscle activity 
that was approaching significance.  As mentioned before, the size and weight of 
hypertrophic breasts may cause a change in the location of the body’s center of gravity.  
As a subject bends down to pick up a pencil, the size and weight of the breasts may pull 
the head further away from the center of gravity than it already was. As the distance from 
the head to the center of gravity increases, the greater the amount of midcervical muscle 
tension required to sustain the weight of the head in this position becomes [8].  In the 
pencil task, women with hypertrophic breast exhibited 7.91%MVC muscle activation 
compared to only 3.12%MVC muscle activation in the midcervical muscles of normal 
control subjects.     
While bending down to pick up a pencil, it appears that women with hypertrophic 
breasts may compensate for increased midcervical activation by activating the lower 
trapezius muscles in an attempt to keep the head and neck in a more upright position.  
Women in the hypertrophy group exhibited 3.23%MVC muscle activation in the lower 
trapezius while women in the normal control exhibited on 2.53%MVC muscle activation 
during the pencil task.  While this difference is only approaching significance, it may 
provide important insight to the compensatory mechanisms used by the musculoskeletal 
system to compensate for hypertrophic breasts.    
  
71 
Posture and Muscle Activation Relationship 
While the muscle activation differences between the two groups were not 
significant, higher levels of muscle activation exhibited by hypertrophy subjects during 
both static posture and tasks of daily living may be related to the altered static postural 
alignment exhibited by these same subjects.  An example of this relationship can be seen 
in the lower amount of low back (erector spinae) activation in the normal control group 
during static trials.  Normal control group subjects exhibited less anterior pelvic tilt, 
resulting in a lesser degree of lumbar lordosis.  This flattening out of the lumbar lordosis 
affects the thoracic spine, which extends slightly to adjust the center of gravity of the 
trunk so that the energy expenditure, in terms of muscle exertion (activation), is 
minimized [42]. 
As stated earlier in this document, posturally induced muscular weakness, or 
“stretch weakness,” has been defined as the effect on muscles of remaining in a 
lengthened condition, however slight, beyond the neutral (physiological rest) position 
[26]. Changes in the direction of muscle pull as a result of an altered static skeletal 
alignment may affect the amount of muscle tension required to maintain a static position, 
thus possibly explaining chronic musculoskeletal weakness and pain experienced by 
women with breast hypertrophy. 
Limitations and Future Research 
One major limitation of this study is the hand position in which subjects were 
required to maintain throughout the data collection session.  During times of data capture, 
  
72 
subjects were required to place their hands on their hips throughout the duration of part or 
in some cases the whole task.  While this is not necessarily a natural, relaxed position, it 
was necessary in order to prevent signal blockage or accidental contact to the sEMG 
electrode on the serratus anterior.  Therefore, it is possible that this position altered the 
mechanics by which each task of daily living was performed, and may have caused a 
slight deviation in the subject’s “normal” posture during static trials.  However, since this 
hand position was uniform across all subjects for all trials, it is unlikely that it had a 
significant effect on the results of this study. 
Another limitation associated with this study is the large standard deviation in 
posture data between subjects.  The explanation for this error can be traced to issues in 
the performance of the tasks of daily living.  Subjects were given the same basic 
instructions about how to perform each task. However in an effort to evaluate each 
subject’s “natural” posture and mechanics used to perform each task, subjects were given 
instructions to perform each task as they “normally would.”  As a result there may have 
been a larger amount of variance in the performance of each task than was anticipated 
(i.e. bending at the waist to pick up a pencil will result in greater values of torso flexion 
than squatting down to pick up a pencil).  Figures 18-21 provide a graphical 
representation of the differences between a normal control subject and a hypertrophy 
subject’s average head flexion, pelvic tilt, scapular protraction, and torso flexion, 
respectively during the performance the pencil task.   
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Average Head Flexion during the Pencil Task
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Figure 18.  Comparison of Average Head Flexion during the Pencil Task 
 
Average Pelvic Tilt during the Pencil Task
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Figure 19.  Comparison of Average Pelvic Tilt during the Pencil Task 
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Average Scapular Protraction during the Pencil Task
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Figure 20.  Comparison of Average Scapular Protraction during the Pencil Task 
 
Average Torso Flexion during the Pencil Task
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Figure 21. Comparison of Average Torso Flexion during the Pencil Task  
 
This difference in movement between subjects may cause a change in the 
normalized values for movement during tasks of daily living (either an increase or 
decrease in value), possibly creating an outlier.  While every effort was made to remove 
the most extreme outliers in the data set, some mild outliers may have remained and been 
included in the final analysis.  Therefore, the variance in the performance of the tasks of 
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daily living needs to be lowered so that the normalized data results are more consistent 
between subjects and the possibility of outliers is reduced.   
Another limitation of this study is large standard deviations in the muscle 
activation data.  This error may be traced back to the performance of MVC’s since the 
resulting EMG signal is used to normalize all other tasks.  The issues lie within the 
subjects and whether or not they fully exerted themselves during the MVC.  If a subject 
did not fully exert herself during the MVC but did during one of the tasks, a value for 
normalized muscle activation (%MVC) greater than 100% could result.  Therefore 
variance in the performance of the MVC needs to be lowered so that the normalized data 
results are more consistent between subjects.  
Finally, of greatest limitation in this study is the power of each statistical test.  
Statistically it is ideal for each dependent variable’s t-test to have a power of at least 0.80; 
meaning β (probability of making a type II error) has a value of 0.20.  However, because 
the sample population in this study is so small and because the standard deviations for 
each task are so high, the resulting power for each test is low.  As a result, some of the 
significant differences that were reported may not in fact be truly statistically significant 
because the power is too low.  It can be postulated that a larger sample size is needed to 
detect a statistical significant difference in the dependent variables analyzed in this study 
since the differences between groups were so small.  Based on data from this study, each 
group should have a population of at least 20 subjects in order to achieve the desirable 
power and to see true statistical differences between the two groups.     
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In terms of the design of this study, it is important to remember that all subjects 
were women who have never undergone nor have even been approved for breast 
augmentation surgery.  It was important to study women who were not actively seeking 
breast reduction surgery in order to investigate trends in the musculoskeletal data for the 
“normal” population.  Future research should examine women who have been approved 
for breast reduction surgery, and investigate differences in musculoskeletal biomechanics 
pre and postoperatively.  Information from future research could provide strong scientific 
evidence of the medical necessity of reduction mammaplasty, thus changing criteria 
insurance companies use to determine eligibility for coverage.   
Conclusions 
 Results of this study provide scientific information regarding the effects of breast 
hypertrophy on the musculoskeletal system.  Of greatest interest, are the slight 
differences in both upper body posture and muscle activation seen in women with larger 
breast sizes under static conditions.  Under static conditions, women with larger breasts 
exhibited increased head flexion, pelvic tilt, and torso flexion.  Women with larger 
breasts also exhibited higher values of muscle activation in the midcervical neck muscles, 
upper trapezius, lower trapezius, serratus anterior, and erector spinae during static 
conditions, indicating an increase in muscle force required to maintain an upright 
position.  While none of the postural alterations seen in women with large breasts were 
statistically significantly different from those seen in women with smaller breasts, the 
data presented shows a clinical trend towards altered musculoskeletal alignment due to 
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the size and weight of larger breasts.  Therefore, results of this study provide scientific 
evidence of the physical burdens placed on the musculoskeletal system in the case of 
breast hypertrophy, and should be considered when determining the medical necessity of 
reduction mammaplasty.    
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APPENDIX A 
Breast Related Symptoms Questionnaire 
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Copy of the questionnaire each subject completed prior to data collection [21]. 
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APPENDIX B 
Pictures of Surface Electrode Placement 
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Figure B 1.  Midcervical (C-4) Paraspinal Electrode Placement 
 
 
Figure B 2.  Upper Trapezius Surface Electrode Placement 
 
 
Figure B 3.  Lower Trapezius Surface Electrode Placement 
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Figure B 4.  Serratus Anterior Surface Electrode Placement 
 
 
Figure B 5.  Erector Spinae Surface Electrode Placement 
  
88 
APPENDIX C 
Pictures of Complete Subject Setup 
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Figure C 1.  Complete Subject Setup (Posterior View) 
 
 
Figure C 2.  Complete Subject Setup (Side View) 
